Borrowing Against Private or Pre-IPO Company Stock.

You can sometimes borrow against shares in a private or pre-IPO company, but the collateral behaves nothing like a listed position, and the structure changes accordingly: lower advance rates, tighter terms, and, often, a liquidity event as the real exit.

A great deal of paper wealth sits in unlisted form — founders and early employees of companies that have not yet gone public, holders of stakes in private groups, investors in businesses years away from a listing. The question of whether that wealth can be borrowed against, without waiting for an IPO or a sale, is a common one. The honest answer is: sometimes, and never on the same terms as listed stock. This note explains why, and what makes private collateral different. It is general information, not legal, tax, or investment advice.

The core difference: no public market

Everything a lender does with listed collateral leans on the existence of a public market. A screen price marks the position every day; a stock exchange provides a venue to sell into on default; daily volume tells the lender how quickly it could exit without moving the price. Private shares have none of this. There is no continuous price, no ready venue, and no observable liquidity — so the lender cannot value the collateral, monitor it, or realise it in the way a listed pledge allows. That single fact drives every other difference.

Valuation without a screen price

Absent a market price, value has to be established some other way — a recent primary or secondary round, a third-party valuation, or a pending transaction — and each of these is staler and softer than a live quote. A lender will discount heavily for that uncertainty, which is one reason advance rates against private stock sit well below the illustrative 20% to 65% envelope that applies to liquid listed names; the loan-to-value logic itself is the same as in Loan-to-Value Calibration, but the inputs are weaker, so the output is lower.

Transfer restrictions and rights of first refusal

Private company shares almost always carry contractual restrictions on transfer — company consent requirements, rights of first refusal, co-sale and drag-along provisions, and outright bans on pledging in some shareholder agreements. These matter enormously to a lender, because they can prevent the one thing the lender needs on default: the ability to take and sell the collateral. A pledge over shares the holder is not permitted to transfer is of little use as security. So the shareholder agreement and the company’s constitution are read first, and often the company’s acknowledgement or consent is a precondition to any facility. This is a sharper version of the restriction analysis in Can You Borrow Against Restricted or Lock-Up Shares?

The information a lender needs

With a listed company, disclosure is continuous and public. With a private one, the lender depends on what the holder and the company are willing and able to share — the capitalisation table, the most recent financing terms, any preferences or liquidation waterfalls that sit ahead of the holder’s class, and the transfer provisions. A common stakeholder’s position can look very different once senior preferences are accounted for. The quality and completeness of that information is often what determines whether a facility can be arranged at all.

How the structure adapts

Where private collateral can be financed, the structure reflects the added risk: a materially lower advance rate, tighter covenants, and frequently a defined exit — a coming IPO, a secondary sale, or a known transaction — against which the loan is sized and timed, rather than an open-ended pledge marked to a daily price. In the pre-IPO case in particular, the facility is often built as a bridge to the listing, with the lock-up regime that will apply after the IPO mapped in advance; the release-window mechanics are set out in Post-IPO Lock-Up Regimes. The nearer and more certain the liquidity event, the more workable the financing.

The practical position

For a holder of private or pre-IPO stock, the realistic expectation is this: financing may be possible where the shares can actually be pledged and transferred, where value can be established with reasonable confidence, and where there is a credible path to liquidity — but on more conservative terms than a listed position, and only after the shareholder documentation has been read closely. Each of these points is confirmed against the holder’s own legal and tax advice and, where required, with the company itself.